Approximately 800,000 children and 1 million elderly people died of pneumonia around the world in 2017. Nevertheless, the severity of pneumonia is of1
COVID-19 affects people with Parkinson’s disease in a similar way to the general population, but it may be more serious in cases of advanced disease.1
In a retrospective study with 80 kidney transplant patients with COVID-19, treatment with tocilizumab demonstrates a decrease in one of the inflammat1
The pandemic and lockdown caused by COVID-19 have increased symptoms of anxiety and depression in the population. However, according to a major surve1
Thrombosis, especially venous thrombosis, are one of the serious complications that can appear in patients affected by COVID-19. These complications,1
During the COVID-19 pandemic, allergists and other specialists such as pulmonologists, ENT specialists, internists and dermatologists have attended t1
The SARS-CoV2 pandemic has impacted society in very diverse ways. Many people have changed their habits due to lockdown, such as practising physical1
Hospital Clínic de Barcelona-IDIBAPS and Cellnex have today signed an agreement to launch a multicentre research project that will allow better under1
Active or past infection was detected among 11.2% of the Hospital Clinic staff that participated in the study.
These are the first results of a global clinical trial in which the Hospital Clinic and ISGlobal participate.
